Tairen Capital LTD Dexcom Inc Transaction History

Tairen Capital LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $1.08 Million - $1.69 Million	-29,421 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $414,954 - $511,540	-11,679 Reduced 28.42%	29,421 $4.39 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $1.14 Million - $1.6 Million	41,100 New	41,100 $6.16 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Tairen Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Tairen Capital LTD with notifications on news.